Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Should Calculate 2003 OPPS Update Using Clinical Trial Cost Data

This article was originally published in The Gray Sheet

Executive Summary

The dissemination of breakthrough technologies of limited market potential is hindered by the design of the hospital outpatient prospective payment system (OPPS), health consulting firm Medical Technology Partners asserts
Advertisement

Related Content

Legislation Easing IPPS New Tech Add-On Criteria Anticipated This Year
OPPS Pass-Through Category Needed For Ascension’s MCP and PIP – MDMA
OPPS Pass-Through Category Needed For Ascension’s MCP and PIP – MDMA
Ascension MCP Joint Replacement Approval Includes Follow-Up Requirement
Ascension MCP Joint Replacement Approval Includes Follow-Up Requirement
Advertisement
UsernamePublicRestriction

Register

MT016405

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel